Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis.

Lung cancer is caused by combinations of diverse genetic mutations. Here, to understand the relevance of nuclear receptors (NRs) in the oncogene-associated lung cancer pathogenesis, we investigated the expression profile of the entire 48 NR members by using QPCR analysis in a panel of human bronchia...

Full description

Bibliographic Details
Main Authors: Jihye Kim, Mitsuo Sato, Jong-Whan Choi, Hyun-Won Kim, Byung-Il Yeh, Jill E Larsen, John D Minna, Jeong-Heon Cha, Yangsik Jeong
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4526668?pdf=render
_version_ 1818268274014552064
author Jihye Kim
Mitsuo Sato
Jong-Whan Choi
Hyun-Won Kim
Byung-Il Yeh
Jill E Larsen
John D Minna
Jeong-Heon Cha
Yangsik Jeong
author_facet Jihye Kim
Mitsuo Sato
Jong-Whan Choi
Hyun-Won Kim
Byung-Il Yeh
Jill E Larsen
John D Minna
Jeong-Heon Cha
Yangsik Jeong
author_sort Jihye Kim
collection DOAJ
description Lung cancer is caused by combinations of diverse genetic mutations. Here, to understand the relevance of nuclear receptors (NRs) in the oncogene-associated lung cancer pathogenesis, we investigated the expression profile of the entire 48 NR members by using QPCR analysis in a panel of human bronchial epithelial cells (HBECs) that included precancerous and tumorigenic HBECs harboring oncogenic K-rasV12 and/or p53 alterations. The analysis of the profile revealed that oncogenic alterations accompanied transcriptional changes in the expression of 19 NRs in precancerous HBECs and 15 NRs according to the malignant progression of HBECs. Amongst these, peroxisome proliferator-activated receptor gamma (PPARγ), a NR chosen as a proof-of-principle study, showed increased expression in precancerous HBECs, which was surprisingly reversed when these HBECs acquired full in vivo tumorigenicity. Notably, PPARγ activation by thiazolidinedione (TZD) treatment reversed the increased expression of pro-inflammatory cyclooxygenase 2 (COX2) in precancerous HBECs. In fully tumorigenic HBECs with inducible expression of PPARγ, TZD treatments inhibited tumor cell growth, clonogenecity, and cell migration in a PPARγ-sumoylation dependent manner. Mechanistically, the sumoylation of liganded-PPARγ decreased COX2 expression and increased 15-hydroxyprostaglandin dehydrogenase expression. This suggests that ligand-mediated sumoylation of PPARγ plays an important role in lung cancer pathogenesis by modulating prostaglandin metabolism.
first_indexed 2024-12-12T20:35:53Z
format Article
id doaj.art-f1d8952e79974d929021b973387cc003
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T20:35:53Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-f1d8952e79974d929021b973387cc0032022-12-22T00:12:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01108e013484210.1371/journal.pone.0134842Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis.Jihye KimMitsuo SatoJong-Whan ChoiHyun-Won KimByung-Il YehJill E LarsenJohn D MinnaJeong-Heon ChaYangsik JeongLung cancer is caused by combinations of diverse genetic mutations. Here, to understand the relevance of nuclear receptors (NRs) in the oncogene-associated lung cancer pathogenesis, we investigated the expression profile of the entire 48 NR members by using QPCR analysis in a panel of human bronchial epithelial cells (HBECs) that included precancerous and tumorigenic HBECs harboring oncogenic K-rasV12 and/or p53 alterations. The analysis of the profile revealed that oncogenic alterations accompanied transcriptional changes in the expression of 19 NRs in precancerous HBECs and 15 NRs according to the malignant progression of HBECs. Amongst these, peroxisome proliferator-activated receptor gamma (PPARγ), a NR chosen as a proof-of-principle study, showed increased expression in precancerous HBECs, which was surprisingly reversed when these HBECs acquired full in vivo tumorigenicity. Notably, PPARγ activation by thiazolidinedione (TZD) treatment reversed the increased expression of pro-inflammatory cyclooxygenase 2 (COX2) in precancerous HBECs. In fully tumorigenic HBECs with inducible expression of PPARγ, TZD treatments inhibited tumor cell growth, clonogenecity, and cell migration in a PPARγ-sumoylation dependent manner. Mechanistically, the sumoylation of liganded-PPARγ decreased COX2 expression and increased 15-hydroxyprostaglandin dehydrogenase expression. This suggests that ligand-mediated sumoylation of PPARγ plays an important role in lung cancer pathogenesis by modulating prostaglandin metabolism.http://europepmc.org/articles/PMC4526668?pdf=render
spellingShingle Jihye Kim
Mitsuo Sato
Jong-Whan Choi
Hyun-Won Kim
Byung-Il Yeh
Jill E Larsen
John D Minna
Jeong-Heon Cha
Yangsik Jeong
Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis.
PLoS ONE
title Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis.
title_full Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis.
title_fullStr Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis.
title_full_unstemmed Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis.
title_short Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis.
title_sort nuclear receptor expression and function in human lung cancer pathogenesis
url http://europepmc.org/articles/PMC4526668?pdf=render
work_keys_str_mv AT jihyekim nuclearreceptorexpressionandfunctioninhumanlungcancerpathogenesis
AT mitsuosato nuclearreceptorexpressionandfunctioninhumanlungcancerpathogenesis
AT jongwhanchoi nuclearreceptorexpressionandfunctioninhumanlungcancerpathogenesis
AT hyunwonkim nuclearreceptorexpressionandfunctioninhumanlungcancerpathogenesis
AT byungilyeh nuclearreceptorexpressionandfunctioninhumanlungcancerpathogenesis
AT jillelarsen nuclearreceptorexpressionandfunctioninhumanlungcancerpathogenesis
AT johndminna nuclearreceptorexpressionandfunctioninhumanlungcancerpathogenesis
AT jeongheoncha nuclearreceptorexpressionandfunctioninhumanlungcancerpathogenesis
AT yangsikjeong nuclearreceptorexpressionandfunctioninhumanlungcancerpathogenesis